查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1866499

介入心臟病學市場－2025-2030年預測

Interventional Cardiology Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 148 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

介入心臟病學市場預計將從 2025 年的 260.96 億美元成長到 2030 年的 347.42 億美元，複合年成長率為 5.89%。

由於微創手術的日益普及和心血管疾病（CVD）盛行率的上升，全球介入心臟病學市場預計將迎來強勁成長。介入心臟病學利用導管（插入體內的細長軟管）治療受損血管、狹窄動脈和其他心臟疾病，透過血管成形術和瓣膜修復/置換術等手術，為開胸手術提供了一種替代方案。導管類器械的技術進步提高了手術的精準度和病患療效，進而推動了市場發展。然而，嚴格的器械核准監管要求以及高成本，尤其是在開發中國家經濟體和低度開發經濟體，都對市場擴張構成了挑戰。

市場促進因素

心血管疾病呈上升趨勢

全球心血管疾病負擔持續加重，是介入心臟病學市場的主要驅動力。心血管疾病（CVD）是全球主要死因之一，亟需先進的治療方案，進而推動了對微創介入手術的需求。冠狀動脈疾病和瓣膜性心臟病等疾病發病率的不斷上升，促使人們採用導管介入手術，與傳統手術相比，導管介入手術恢復更快，風險更低。

醫療設備創新

介入心臟病學器材的創新，例如新一代支架、球囊和影像導引導管，正顯著推動市場成長。這些進步提高了手術的精準性、安全性和有效性，從而改善了複雜心血管疾病的治療。改進的器械設計，例如生物可吸收支架和先進的瓣膜修復系統，正在拓展治療選擇，進一步刺激市場需求。

全球醫療保健成本不斷上漲

全球醫療保健支出不斷成長，尤其是在已開發經濟體和新興經濟體，這推動了介入心臟病學市場的成長。醫療基礎設施投資的增加以及先進醫療技術的普及，促進了微創手術的採用，刺激了對專業心臟病學設備的需求，並創造了新的市場機會。

市場限制

嚴格的監管要求

介入心臟病學器材的核准流程受到嚴格的監管審查，這可能會延遲產品上市並增加研發成本。遵守各地不同的標準，尤其是在北美和歐洲，對製造商來說是一項挑戰，並可能減緩市場成長。

開發中國家國家的高成本

介入心臟病學手術和設備的高成本限制了開發中國家和低度開發經濟體的醫療服務獲取，這些地區的醫療預算和病患支付能力都較為有限。這種支付能力差距阻礙了高成長地區的市場滲透，並限制了整體擴張。

市場區隔與區域展望

從地理上看，北美和歐洲的介入心臟病學市場主導顯著成長，這主要得益於先進的醫療保健體系、較高的心血管疾病（CVD）患病率以及健全的研發生態系統。亞太地區預計也將迎來顯著成長，這主要得益於醫療保健投資的增加、疾病負擔的加重以及中國和印度等國家先進療法的可及性提高。

主要企業

介入心臟病學市場的主要企業包括Medtronic、史賽克、雅培、貝朗-梅爾松根公司、波士頓科學、科迪斯（康德樂）、愛德華生命科學、通用電氣醫療集團、生物感測器國際集團和百多力公司。這些公司正專注於創新、策略夥伴關係和產品組合擴展，以保持其競爭優勢。

產業展望

介入心臟病學市場預計將持續成長，主要受心血管疾病負擔加重、技術進步和醫療保健投資增加的推動。儘管監管和成本方面的挑戰依然存在，但該市場與微創趨勢和亞太地區經濟成長的契合預計將推動其顯著擴張，為相關人員創造滿足未被滿足的醫療需求的機會。

本報告的主要優勢：

  • 深入分析：取得以客戶群、政府政策和社會經濟因素、消費者偏好、垂直產業和其他細分市場為重點的深入市場洞察，涵蓋主要地區和新興地區。
  • 競爭格局：了解主要企業採取的策略舉措，並了解透過正確的策略打入市場的潛力。
  • 市場促進因素與未來趨勢：探索動態因素和關鍵市場趨勢，以及它們將如何塑造未來的市場發展。
  • 可執行的建議：利用洞察力為策略決策提供訊息，從而在動態環境中開拓新的業務管道和收入來源。
  • 受眾範圍廣：對新興企業、研究機構、顧問公司、中小企業和大型企業都有益處且經濟高效。

它是用來做什麼的？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及影響、新產品開發、競爭影響

分析範圍

  • 歷史資料（2022-2024 年）和預測資料（2025-2030 年）
  • 成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
  • 競爭對手定位、策略和市場佔有率分析
  • 按業務板塊和地區（國家）分類的收入成長和預測分析
  • 公司概況（策略、產品、財務資訊、關鍵趨勢等）

目錄

第1章執行摘要

第2章市場概述

  • 市場概覽
  • 市場定義
  • 分析範圍
  • 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策和法規
  • 策略建議

第4章 技術展望

第5章 按器械類型介入心臟病學市場

  • 介紹
  • 支架
    • 藥物釋放型支架（DES）
    • 裸金屬支架（BMS）
    • 生物可吸收支架
  • 導管
    • 診斷導管
    • 引導管
  • 經皮冠狀動脈介入治療（PTCA）球囊
    • 傳統球囊血管成形術（POBA）球囊
    • 切割/球囊導管
    • 藥物釋放型球囊（DCB）
  • 動脈粥狀硬化斑塊切除術裝置
  • 斑塊調節裝置
  • 導管導引線
  • 栓塞保護裝置
  • 其他

第6章 按應用分類的介入心臟病學市場

  • 介紹
  • 冠狀動脈疾病
  • 瓣膜性心臟病
    • 經導管主動脈瓣置換術（TAVR）
    • 經導管二尖瓣瓣膜修復/置換術（TMVR）
  • 周邊血管疾病
  • 結構性心臟疾病
    • 心房中膈缺損症（ASD）封堵術
    • 卵圓孔未閉合（PFO）封堵術
    • 左心耳封堵術（LAA封堵術）
  • 先天性心臟疾病

第7章介入心臟病學市場（依最終用戶分類）

  • 介紹
  • 醫院和診所
  • 門診手術中心（ASC）
  • 專業心臟中心

第8章：介入心臟病學市場區域分析

  • 介紹
  • 北美洲
    • 依設備類型
    • 透過使用
    • 最終用戶
    • 按國家/地區
      • 美國
      • 加拿大
      • 墨西哥
  • 南美洲
    • 依設備類型
    • 透過使用
    • 最終用戶
    • 按國家/地區
      • 巴西
      • 阿根廷
      • 其他
  • 歐洲
    • 依設備類型
    • 透過使用
    • 最終用戶
    • 按國家/地區
      • 英國
      • 德國
      • 法國
      • 西班牙
      • 其他
  • 中東和非洲
    • 依產品類型
    • 透過使用
    • 按國家/地區
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 其他
  • 亞太地區
    • 依設備類型
    • 透過使用
    • 最終用戶
    • 按國家/地區
      • 中國
      • 日本
      • 印度
      • 韓國
      • 台灣
      • 其他

第9章 競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 企業合併、協議、商業合作
  • 競爭對手儀錶板

第10章：公司簡介

  • Medtronic
  • Stryker
  • Abbott
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Cordis
  • Edwards Lifesciences Corporation
  • GE Healthcare
  • Biosensors International Group, Ltd.
  • Biotronik, Inc.

第11章附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要收益
  • 分析方法
  • 簡稱
簡介目錄
Product Code: KSI061611750

The Interventional Cardiology Market is projected to expand from USD 26.096 billion in 2025 to USD 34.742 billion in 2030, registering a 5.89% compound annual growth rate (CAGR).

The global interventional cardiology market is poised for robust growth, driven by the increasing adoption of minimally invasive procedures and the rising prevalence of cardiovascular diseases (CVDs). Interventional cardiology utilizes catheters-thin, flexible tubes inserted into the body-to treat damaged vessels, narrowed arteries, and other heart conditions, offering alternatives to open surgery through procedures like angioplasty and valve repair or replacement. The market is supported by technological advancements in catheter-based devices, which enhance procedural precision and patient outcomes. However, stringent regulatory requirements for device approvals and the high cost of procedures, particularly in developing and underdeveloped economies, pose challenges to market expansion.

Market Drivers

Increasing Prevalence of Cardiovascular Diseases

The global burden of cardiovascular diseases remains a primary driver of the interventional cardiology market. As a leading cause of mortality worldwide, CVDs necessitate advanced treatment options, boosting demand for minimally invasive interventions. The growing incidence of conditions such as coronary artery disease and heart valve disorders is driving the adoption of catheter-based procedures, which offer reduced recovery times and lower risks compared to traditional surgery.

Technological Advancements in Devices

Innovations in interventional cardiology devices, including next-generation stents, balloons, and imaging-guided catheters, are significantly propelling market growth. These advancements improve procedural accuracy, safety, and efficacy, enabling better management of complex cardiovascular conditions. Enhanced device designs, such as bioresorbable stents and advanced valve repair systems, are expanding treatment options, further fueling market demand.

Increasing Health Expenditure Worldwide

Rising global healthcare expenditure, particularly in developed and emerging economies, is supporting the growth of the interventional cardiology market. Increased investments in healthcare infrastructure and access to advanced medical technologies are enabling wider adoption of minimally invasive procedures, driving demand for specialized cardiology devices and expanding market opportunities.

Market Restraints

Stringent Regulatory Requirements

The approval process for interventional cardiology devices is subject to rigorous regulatory scrutiny, which can delay market entry and increase development costs. Compliance with diverse regional standards, particularly in North America and Europe, poses challenges for manufacturers, potentially slowing market growth.

High Cost in Developing Economies

The high cost of interventional cardiology procedures and devices limits accessibility in developing and underdeveloped economies, where healthcare budgets and patient affordability are constrained. This affordability gap restricts market penetration in high-growth regions, hindering overall expansion.

Market Segmentation and Geographical Outlook

The interventional cardiology market is segmented by geography, with North America and Europe leading due to advanced healthcare systems, high CVD prevalence, and robust R&D ecosystems. Asia-Pacific is expected to exhibit significant growth, driven by rising healthcare investments, increasing disease burdens, and improving access to advanced treatments in countries like China and India.

Key Players

Major players in the interventional cardiology market include Medtronic, Stryker, Abbott, B. Braun Melsungen AG, Boston Scientific Corporation, Cordis (A Cardinal Health Company), Edwards Lifesciences Corporation, GE Healthcare, Biosensors International Group, Ltd., and Biotronik, Inc. These companies focus on innovation, strategic partnerships, and portfolio expansion to maintain competitive advantage.

Industry Outlook

The interventional cardiology market is set for sustained growth, driven by the rising CVD burden, technological advancements, and increasing healthcare investments. While regulatory and cost-related challenges persist, the market's alignment with minimally invasive trends and regional growth in Asia-Pacific positions it for significant expansion, offering opportunities for stakeholders to address unmet medical needs.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation

By Device Type

  • Stents
  • Drug-Eluting Stents (DES)
  • Bare-Metal Stents (BMS)
  • Bioabsorbable Stents
  • Catheters
  • Diagnostic Catheters
  • Guiding Catheters
  • Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons
  • Plain Old Balloon Angioplasty (POBA) Balloons
  • Cutting/Scoring Balloons
  • Drug-Coated Balloons (DCB)
  • Atherectomy Devices
  • Plaque Modification Devices
  • Guidewires
  • Embolic Protection Devices
  • Others

By Application

  • Coronary Artery Disease
  • Heart Valve Disease
  • Transcatheter Aortic Valve Replacement (TAVR)
  • Transcatheter Mitral Valve Repair/Replacement (TMVR)
  • Peripheral Vascular Disease
  • Structural Heart Disease
  • Atrial Septal Defect (ASD) Closure
  • Patent Foramen Ovale (PFO) Closure
  • Left Atrial Appendage (LAA) Closure
  • Congenital Heart Defects

By End-User

  • Hospitals and Clinics
  • Ambulatory Surgery Centers (ASCs)
  • Specialty Cardiac Centers

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. INTERVENTIONAL CARDIOLOGY MARKET BY DEVICE TYPE

  • 5.1. Introduction
  • 5.2. Stents
    • 5.2.1. Drug-Eluting Stents (DES)
    • 5.2.2. Bare-Metal Stents (BMS)
    • 5.2.3. Bioabsorbable Stents
  • 5.3. Catheters
    • 5.3.1. Diagnostic Catheters
    • 5.3.2. Guiding Catheters
  • 5.4. Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons
    • 5.4.1. Plain Old Balloon Angioplasty (POBA) Balloons
    • 5.4.2. Cutting/Scoring Balloons
    • 5.4.3. Drug-Coated Balloons (DCB)
  • 5.5. Atherectomy Devices
  • 5.6. Plaque Modification Devices
  • 5.7. Guidewires
  • 5.8. Embolic Protection Devices
  • 5.9. Others

6. INTERVENTIONAL CARDIOLOGY MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Coronary Artery Disease
  • 6.3. Heart Valve Disease
    • 6.3.1. Transcatheter Aortic Valve Replacement (TAVR)
    • 6.3.2. Transcatheter Mitral Valve Repair/Replacement (TMVR)
  • 6.4. Peripheral Vascular Disease
  • 6.5. Structural Heart Disease
    • 6.5.1. Atrial Septal Defect (ASD) Closure
    • 6.5.2. Patent Foramen Ovale (PFO) Closure
    • 6.5.3. Left Atrial Appendage (LAA) Closure
  • 6.6. Congenital Heart Defects

7. INTERVENTIONAL CARDIOLOGY MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals and Clinics
  • 7.3. Ambulatory Surgery Centers (ASCs)
  • 7.4. Specialty Cardiac Centers

8. INTERVENTIONAL CARDIOLOGY MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Device Type
    • 8.2.2. By Application
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Device Type
    • 8.3.2. By Application
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Device Type
    • 8.4.2. By Application
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Spain
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Product Type
    • 8.5.2. By Application
    • 8.5.3. By Country
      • 8.5.3.1. Saudi Arabia
      • 8.5.3.2. UAE
      • 8.5.3.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Device Type
    • 8.6.2. By Application
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Taiwan
      • 8.6.4.6. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Medtronic
  • 10.2. Stryker
  • 10.3. Abbott
  • 10.4. B. Braun Melsungen AG
  • 10.5. Boston Scientific Corporation
  • 10.6. Cordis
  • 10.7. Edwards Lifesciences Corporation
  • 10.8. GE Healthcare
  • 10.9. Biosensors International Group, Ltd.
  • 10.10. Biotronik, Inc.

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key benefits for the stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations